血液型タイピング市場：技術、検査、製品タイプ、エンドユーザー別-2024～2030年の世界予測

血液型タイピング市場規模は2023年に33億7,000万米ドルと推定され、2024年には36億3,000万米ドルに達し、CAGR 7.82%で2030年には57億2,000万米ドルに達すると予測されています。

血液型タイピングは、血液型判定または血液分類としても知られ、輸血医療と移植において極めて重要なプロセスです。赤血球（RBC）表面の特定の抗原、タンパク質、炭水化物を識別し、個人の血液型を決定します。安全な輸血の実践に対する世界の需要の増加は、市場成長の主要要因の一つです。このような需要は、頻繁な輸血を必要とする慢性疾患の有病率の増加によって生じています。しかし、分子アッセイなどの高度な試験技術に関連するコストが高いため、特に低資源環境ではその導入が制限されています。高度な機器を操作できる熟練した専門家の不足も、業界が直面する重大な課題です。さらに、政府のイニシアティブにより医療インフラが改善され、民間組織からの投資が増加することで、市場参入企業に機会がもたらされます。次世代シーケンシング（NGS）を含む自動化技術を採用することで、試験中の人的ミスを減らしながらスループット能力を大幅に向上させることができます。

技術：アッセイベースと超並列シーケンス技術の採用が増加

アッセイベースの技術は、迅速で正確な結果を提供する血液型タイピングに広く使用されています。血清学的または分子学的手法を用いて、赤血球表面の特定の抗原を検出する試薬を使用します。MPS（Massively Parallel Sequencing）またはNGS（Next-Generation Sequencing）は、複数のゲノム領域を同時に解析できる高度な技術です。マイクロアレイ技術は、様々な遺伝子やゲノム領域の同時解析を可能にする、ゲノミクス研究で利用されるハイスループット手法です。

試験の種類抗原を検出するABO血液試験とヒト白血球抗原タイピング試験の急速な出現

ABO式血液試験は、個人の血液型（A、B、AB、O）を特定するための最も基本的で広く用いられている方法です。これらの試験は、赤血球上のA抗原とB抗原、血漿中の対応する抗体の存在を検出します。抗体スクリーニング試験は、輸血や臓器移植の際に副作用を引き起こす可能性のある、血漿中の臨床的に重要な抗体を特定するのに役立ちます。抗原タイピング試験は、A抗原とB抗原以外の赤血球上の特定の抗原の有無を判定します。クロス・マッチング・シリーズ試験は、ドナーとレシピエントの血液サンプルの適合性を直接確認するために行われます。ヒト白血球抗原（HLA）タイピングは、ドナーとレシピエントの間で一致するHLA分子を特定することにより、臓器移植における適合性を決定するために極めて重要です。

製品：血液型タイピングサービスにおける消耗品と器具の重要な使用

消耗品は、血液型タイピングにおいて様々な血液型を識別・鑑別するために使用される必須材料です。輸血、出生前医療、臓器移植、研究のための正確で効率的な血液型試験の需要により、消耗品の必要性が高まっています。血液型タイピングで使用される機器には、分析装置、セルソーター、顕微鏡、遠心分離機、リキッドハンドラー、ピペットなどがあり、高い処理能力でサンプルの正確な測定と分析を可能にします。サービスには、病院、診断センター、血液銀行、研究機関が血液型分類に関連する業務を管理するための試験、コンサルティング、トレーニング、アウトソーシングソリューションが含まれます。

エンドユーザー：臨床試験室や病院における血液型タイピングサービスの新たな利用

血液バンクは、血液や血液成分を収集、保管し、病院やクリニックに分配するため、医療産業において極めて重要です。臨床試験室は、病気の発見、モニタリング、予防、治療戦略のための診断テストを実施します。血液型タイピングは、出生前スクリーニング、臓器移植適合性評価、特定の遺伝子疾患の診断に不可欠です。病院は、主に輸血や臓器移植のために血液型タイピングサービスを必要とします。

地域別洞察

米国とカナダでは、高度な医療インフラと膨大な輸血需要を背景に、血液型タイピングの採用が大幅に増加しました。主要企業は最近、NIHが資金提供するNational Blood Donor Projectなどの研究イニシアティブに投資しています。カナダでは、医療機関への政府助成金の増加が血液型タイピング技術の需要を促進しています。アジア太平洋は、医療に対する政府支出の増加と医療技術の進歩により大きな成長を遂げています。中国では、血液型タイピング関連の特許出願が急増しており、調査と市場の可能性を示しています。日本では高齢化が進み、インドでは血液関連疾患に対する意識が高まっているため、正確で効率的な血液タイピングソリューションに対するニーズが高まっています。欧州では、バイオテクノロジーとライフサイエンスへの投資が拡大しており、市場の成長を後押ししています。EUのHorizon 2020プログラムは、「健康のための次世代ICTsに向けて」のイニシアチブを通じて個別化医療研究を優先しています。中東・アフリカ地域は、多様な人口と健康格差からくる独自の課題に直面しています。しかし、医療へのアクセス改善にますます焦点が当てられるようになったことで、血液型タイピングのプロバイダーにはビジネス機会が生まれています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは血液型タイピング市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、血液型タイピング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.血液型タイピング市場の市場規模と予測は？

2.血液型タイピング市場の予測期間中に投資を検討すべき製品、用途は何か？

3.血液型タイピング市場の技術動向と規制枠組みは？

4.血液型タイピング市場における主要ベンダーの市場シェアは？

5.血液型タイピング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 交通事故、緊急事態、外傷の増加
    • 法医療における血液型タイピングの採用増加
    • 輸血に関する厳格な規制基準
  • 抑制要因
    • 認識と熟練した専門家の欠如
  • 機会
    • 血液型タイピングシステムの進歩と発展
    • 血液型タイピングにおける研究開発活動と製品イノベーションの強化
  • 課題
    • 伝染病に関連するリスク
• 市場セグメンテーション分析
  • 技術：アッセイベースと大規模並列シーケンス技術の採用の増加
  • 検査タイプ：抗原を検出するためのABO血液試験とヒト白血球抗原タイピング試験の急速な出現
  • 製品：血液型タイピングサービスにおける消耗品と器具の重要な使用
  • エンドユーザー：臨床試験室や病院における血液型タイピングサービスの新たな利用
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 血液型タイピング市場：技術別

• イントロダクション
• アッセイベースの技術
• 超並列シーケンシング
• マイクロアレイ

第7章 血液型タイピング市場：検査タイプ別

• イントロダクション
• ABO血液試験
• 抗体スクリーニング
• 抗原型判定
• クロスマッチングシリーズ
• ヒト白血球抗原タイピング

第8章 血液型タイピング市場：製品別

• イントロダクション
• 消耗品
• 機器
• サービス

第9章 血液型タイピング市場：エンドユーザー別

• イントロダクション
• 血液バンク
• 臨床試験室
• 病院

第10章 南北アメリカの血液型タイピング市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の血液型タイピング市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの血液型タイピング市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. BLOOD GROUP TYPING MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD GROUP TYPING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BLOOD GROUP TYPING MARKET DYNAMICS
• FIGURE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD GROUP TYPING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ASSAY-BASED TECHNIQUES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ASSAY-BASED TECHNIQUES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MASSIVELY PARALLEL SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MASSIVELY PARALLEL SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ABO BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ABO BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIGEN TYPING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIGEN TYPING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CROSS-MATCHING SERIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CROSS-MATCHING SERIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 53. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 54. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 55. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 56. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 62. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 63. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 64. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 65. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 66. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 69. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 70. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 71. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 72. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 73. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 74. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 75. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 76. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 77. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 78. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 79. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 80. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 81. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 82. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 83. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 86. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 87. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 88. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 89. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 90. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 91. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 92. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 93. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 94. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 96. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 98. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 100. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 102. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 104. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 105. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 106. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 107. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 108. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 109. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 110. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 111. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 114. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 115. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 116. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 117. CHINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 118. CHINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 119. CHINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 120. CHINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 121. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 122. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 123. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 124. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 125. INDIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 126. INDIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 127. INDIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 128. INDIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 129. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 130. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 131. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 132. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 133. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 134. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 135. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 136. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 137. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 138. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 139. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 140. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 141. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 142. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 143. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 144. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 145. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 146. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 147. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 148. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 149. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 150. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 151. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 152. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 153. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 154. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 155. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 156. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 157. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 158. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 159. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 162. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 163. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 164. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 165. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 166. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 167. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 170. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 172. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 174. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 176. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 177. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 178. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 179. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 180. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 181. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 182. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 183. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 186. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 187. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 188. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 189. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 190. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 191. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 194. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 195. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 196. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 197. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 198. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 199. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 211. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 212. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 213. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 214. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 215. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 216. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 217. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 218. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 219. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 220. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 221. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 222. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 223. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 224. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 225. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 226. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 227. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 228. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 229. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 230. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 231. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 232. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 233. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 234. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 235. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 236. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 237. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 238. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 239. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 240. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 241. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 242. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 243. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 244. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 245. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 246. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 247. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 252. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 253. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 254. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 255. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 256. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 257. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 258. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 259. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 260. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 261. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 262. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 263. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 264. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 265. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 266. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 267. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 268. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 269. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 270. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 271. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 272. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 273. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 274. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 275. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 276. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 277. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 278. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 279. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 280. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 281. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 284. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 285. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 286. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 287. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 288. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 289. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 290. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 291. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 292. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 293. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 294. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 295. POLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 296. POLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 297. POLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 298. POLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 299. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 300. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 301. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 302. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 303. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 304. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 305. QATAR BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 306. QATAR BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 307. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 308. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 309. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 310. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 311. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 312. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 313. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 314. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 316. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 318. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 320. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 322. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 324. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 326. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 327. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 328. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 329. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 330. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 331. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 332. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 333. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 334. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 335. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 336. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 337. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 338. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 339. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 340. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 341. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 342. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 343. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 344. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 345. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 346. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 347. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 348. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 349. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 350. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 351. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 352. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 353. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 354. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 355. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2023 (USD MILLION)
• TABLE 356. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2024-2030 (USD MILLION)
• TABLE 357. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 358. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 359. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 360. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 361. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 362. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 363. UNITED ARAB EMIRATES BLO

[193 Pages Report] The Blood Group Typing Market size was estimated at USD 3.37 billion in 2023 and expected to reach USD 3.63 billion in 2024, at a CAGR 7.82% to reach USD 5.72 billion by 2030.

Blood group typing, also known as blood typing or blood classification, is a crucial process in transfusion medicine and transplantation. It involves identifying specific antigens, proteins, and carbohydrates on the surface of red blood cells (RBCs) and determining an individual's blood group. The increasing demand for safe blood transfusion practices worldwide is one of the primary factors contributing to the market growth. This demand arises due to a growing prevalence of chronic diseases that require frequent blood transfusions. However, high costs associated with advanced testing techniques, such as molecular assays, limit their adoption, particularly in low-resource settings. A lack of skilled professionals capable of operating advanced instruments is another critical challenge th industry faces. Additionally, government initiatives improve healthcare infrastructure, and increased investment from private organizations presents opportunities for market players. Adopting automation technologies, including Next-Generation Sequencing (NGS), can significantly enhance throughput capabilities while reducing human errors during testing.

Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques

Assay-based techniques are widely used for blood group typing, offering rapid and accurate results. They involve using reagents to detect specific antigens on red blood cells' surfaces using serological or molecular methods. Massively Parallel Sequencing (MPS), or Next-Generation Sequencing (NGS), is an advanced technique that allows simultaneous analysis of multiple genomic regions. Microarray technology is a high-throughput method utilized in genomics research that enables simultaneous analysis of various genes or genomic regions.

Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens

ABO blood tests are the most basic and widely used method for identifying an individual's blood type (A, B, AB, or O). These tests detect the presence of A and B antigens on red blood cells and corresponding antibodies in plasma. Antibody screening tests help identify clinically significant antibodies in an individual's plasma that may cause adverse reactions during transfusions or organ transplants. Antigen typing tests determine the presence or absence of specific antigens on red blood cells beyond A and B antigens. Cross-matching series tests are performed to ensure donor and recipient blood samples' compatibility directly. Human leukocyte antigen (HLA) Typing is crucial for determining compatibility in organ transplantation by identifying matching HLA molecules between donors and recipients.

Product: Significant use of consumables and instruments in blood group typing services

Consumables are essential materials used in blood group typing to identify and differentiate the various blood groups. The need for consumables has increased due to the demand for accurate and efficient blood group testing for transfusions, prenatal care, organ transplants, and research. Instruments utilized in blood group typing involve devices such as analyzers, cell sorters, microscopes, centrifuges, liquid handlers, and pipettes that enable precise measurement and analysis of samples with high throughput capacity. Blood group typing services encompass testing, consulting, training, and outsourcing solutions that aid hospitals, diagnostic centers, blood banks, and research institutes in managing blood grouping-related activities.

End-User: Emerging use of blood group typing services in clinical laboratories and hospitals

Blood banks are crucial in the healthcare industry as they collect, store, and distribute blood and blood components to hospitals and clinics. Clinical laboratories conduct diagnostic tests for disease detection, monitoring, prevention, or treatment strategies. Blood group typing is essential for prenatal screening, organ transplantation compatibility assessment, or diagnosis of certain genetic conditions. Hospitals require blood group typing services primarily for transfusion purposes and organ transplantation procedures.

Regional Insights

In the Americas, the U.S. and Canada significantly increased the adoption of blood group typing owing to its advanced healthcare infrastructure and huge demand for blood transfusions. Key players have recently invested in research initiatives such as the NIH-funded National Blood Donor Project. In Canada, a rise in government funding for healthcare organizations is driving demand for blood group typing technologies. The Asia-Pacific region is encountering substantial growth due to increased government spending on healthcare and advancements in medical technologies. In China, patent filings related to blood group typing have surged, indicating strong research and market potential. Japan's aging population and India's rising awareness of blood-related disorders drive the need for accurate and efficient blood typing solutions. In Europe, growing investments in biotechnology and life sciences fuel market growth. The EU's Horizon 2020 program has prioritized personalized medicine research through initiatives 'Towards Next-Generation ICTs for Health.' The Middle East and Africa region face unique challenges from their diverse populations and health disparities. However, an increasing focus on improving healthcare access creates opportunities for blood group typing providers.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Group Typing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Group Typing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Group Typing Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Atlas Medical GmbH, AXO Science SAS, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, Biorex Diagnostics, Cardinal Health, Genome Diagnostics B.V., Grifols, S.A., Hemo bioscience, Inc., Lorne Laboratories Limited, Merck KGaA, Quotient Suisse SA, Rapid Labs Ltd, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Techniques
  • Assay-Based Techniques
  • Massively Parallel Sequencing
  • Microarray

• Test Type
  • ABO Blood Tests
  • Antibody Screening
  • Antigen Typing
  • Cross-Matching Series
  • Human Leukocyte Antigen Typing

• Product
  • Consumables
  • Instruments
  • Services

• End-User
  • Blood Banks
  • Clinical Laboratories
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Group Typing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Group Typing Market?

3. What are the technology trends and regulatory frameworks in the Blood Group Typing Market?

4. What is the market share of the leading vendors in the Blood Group Typing Market?

5. Which modes and strategic moves are suitable for entering the Blood Group Typing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of road accidents, emergencies, and trauma
    • 5.1.1.2. Rising adoption of blood group typing in forensic sciences
    • 5.1.1.3. Strict regulatory standards regarding blood transfusion
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of awareness and skilled professional
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and developments in the blood group typing systems
    • 5.1.3.2. Increasing R&D activities and product innovations in blood group typing
  • 5.1.4. Challenges
    • 5.1.4.1. Risk associated with transmissible diseases
• 5.2. Market Segmentation Analysis
  • 5.2.1. Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques
  • 5.2.2. Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens
  • 5.2.3. Product: Significant use of consumables and instruments in blood group typing services
  • 5.2.4. End-User: Emerging use of blood group typing services in clinical laboratories and hospitals
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Blood Group Typing Market, by Techniques

• 6.1. Introduction
• 6.2. Assay-Based Techniques
• 6.3. Massively Parallel Sequencing
• 6.4. Microarray

7. Blood Group Typing Market, by Test Type

• 7.1. Introduction
• 7.2. ABO Blood Tests
• 7.3. Antibody Screening
• 7.4. Antigen Typing
• 7.5. Cross-Matching Series
• 7.6. Human Leukocyte Antigen Typing

8. Blood Group Typing Market, by Product

• 8.1. Introduction
• 8.2. Consumables
• 8.3. Instruments
• 8.4. Services

9. Blood Group Typing Market, by End-User

• 9.1. Introduction
• 9.2. Blood Banks
• 9.3. Clinical Laboratories
• 9.4. Hospitals

10. Americas Blood Group Typing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Blood Group Typing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Blood Group Typing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. My Personal Health Bank Joins Forces with Eldon Biologicals A/S for Innovative Healthcare Solutions incorporating POC Blood Typing
  • 13.3.2. Metropolis Healthcare launches test for HSCT & solid organ transplantation
  • 13.3.3. NHSBT Researchers Discover New Blood Group System
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio